Article Text

other Versions

PDF
Magnetic resonance for assessment of disease activity and severity in Crohn disease
  1. Jordi Rimola (jrimola{at}clinic.ub.es)
  1. Radiology Department, Hospital Clínic de Barcelona, Spain
    1. Sonia Rodríguez (srodrig{at}clinic.ub.es)
    1. Radiology Department, Hospital Clínic de Barcelona, Spain
      1. Orlando García Bosch (ogarcia{at}clinic.ub.es)
      1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain
        1. Ingrid Ordás (iordas{at}clinic.ub.es)
        1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain
          1. Edgar Ayala (eayala{at}clinic.ub.es)
          1. Epidemiology Department, Hospital Clínic de Barcelona, Spain
            1. Montserrat Aceituno (mquinta{at}clinic.ub.es)
            1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain
              1. Maria Pellisé (mpellise{at}clinic.ub.es)
              1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain
                1. Carmen Ayuso (cayuso{at}clinic.ub.es)
                1. Radiology Department, Hospital Clínic de Barcelona, Spain
                  1. Elena Ricart (ericart{at}clinic.ub.es)
                  1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain
                    1. Lluís Donoso (ldonoso{at}clinic.ub.es)
                    1. Radiology Department, Hospital Clínic de Barcelona, Spain
                      1. Julián Panés (jpanes{at}clinic.ub.es)
                      1. Gastroenterology Department, Hospital Clínic de Barcelona, Spain

                        Abstract

                        Objective: Assessment of disease extension and activity is crucial to guide therapy in Crohn disease. The objective of the current study was to determine the accuracy of Magnetic Resonance (MR) for this assessment.

                        Design: 50 patients with clinically active (n=35) or inactive (n=15) Crohn disease underwent ileocolonoscopy (reference standard) and MR. T2-weighted and pre- and post-contrast-enhanced T1-weighted sequences were acquired. Endoscopic activity was evaluated by CDEIS; in addition endoscopic lesions were classified as absent, mild (inflammation without ulcers), or severe (presence of ulceration).

                        Results: The comparison of intestinal segments with absent, mild and severe inflammation demonstrated a progressive and significant (p<0.001) increase in the following MR parameters: wall thickness, post-contrast wall signal intensity, relative contrast enhancement, presence of edema, ulcers, pseudopolyps and lymph node enlargement. Independent predictors for CDEIS in a segment were wall thickness (p=0.007), relative contrast enhancement (p=0.01), presence of edema (p=0.02), and presence of ulcers at MR (p=0.003). There was a significant correlation (r=0.82, p<0.001) between the CDEIS of the segment and the MR index calculated according to the logistic regression analysis coefficients. The MR index had a high accuracy for the detection of disease activity (area ROC curve 0.891, sensitivity 0.81, specificity 0.89) and for the detection of severe lesions (area ROC curve 0.978, sensitivity 0.95, specificity 0.91) in the colon and terminal ileum.

                        Conclusion: The accuracy of MR for detecting disease activity and assessing severity brings about the possibility of using MR as an alternative to endoscopy in the evaluation of Crohn disease.

                        Statistics from Altmetric.com

                        Request permissions

                        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                        Linked Articles

                        • Digest
                          Robin Spiller Severine Vermeire